On the eve of a Parliamentary committee hearing on clinical trial reporting, a new analysis finds that 33 National Health Service sponsors and six U.K. universities failed to report any of their clinical trial results, defying a directive issued earlier this year to submit the missing data.

Last January, Science and Technology Committee chair Norman Lamb wrote more than three dozen universities that they had six months to improve their trial reporting. Since then, he also urged the U.K.’s Health Research Authority to enforce rules and impose penalties on wayward trial sponsors and investigators. Under U.K. law, all trial results must be reported within one year.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
Sign up to receive a free weekly opinions recap from our community of experts.
Privacy Policy